Abstract
| Original language | English |
|---|---|
| Article number | e70070 |
| Pages (from-to) | 1-22 |
| Number of pages | 22 |
| Journal | Aging Cell |
| Volume | 24 |
| Issue number | 7 |
| Early online date | 14 May 2025 |
| DOIs | |
| Publication status | Published (in print/issue) - 31 Jul 2025 |
Bibliographical note
© 2025 The Author(s). Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.Data Availability Statement
scRNAseq data were deposited in the Gene Expression Omnibus (GEO)and can be accessed using reviewer token gjmdcmimzdollol through
the following link: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE132545. The GEO record for RNA-seq can be accessed here:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267432 and
that for ATAC seq can be accessed here: https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE267431 using reviewer token uxypmmeaxdmdjgr. All raw data used to generate the results and figures of this study
are available upon request. This includes scripts used for scRNAseq
analysis, original IHC and IF images, quantification of dermal pigmentation, original Western blot scans, and individual cell counts for
melanoblasts, melanocytes, and McSCs (DCT-LacZ, BrdU, EdU, DCT
immunofluorescence, TAFs, and flow cytometry).
Funding
Funding: Work in the lab of P.D.A. was supported by P01 AG031862-13 and R01 AR078559 and additional funding from the Cancer Research UK Core Funding to the CRUK Glasgow Centre (A25142) and Cancer Research UK Core Funding to the CRUK Scotland Institute (A17196). R.A. was supported by the California Institute for Regenerative Medicine grant EDUC4-12813. L.M.M. was funded by core CRUK grants A15673 and A24452. Work in the lab of J.P.M. was supported by U24 CA220341, U24 CA194107, and U24 CA248457. A.T.W. was supported by NIH grants T15LM011271, F31CA257344, and T32CA067754. A.L. and work in the J.F.P. lab were supported by NIH grants R01AG068048, R01AG82708, UH3CA268103, and P01 AG062413 and The Glenn Foundation For Medical Research. M.L.H. and I.B. were supported by R01 AR078559. C.H.S. and K.Y.Y. were supported by U54 AG079758, R01 AG085498, and R01 CA287114. K.B. was CRUK Core funded (A29799). K.K. was funded by Blood Cancer UK (grant reference 23001), by an EHA Bilateral grant number ID BCG-202209-02649, and by the Mayo Clinic Robert and Arlene Kogod Center on Aging and the Mayo Clinic Department of Hematology. Work in the lab of P.D.A. was supported by P01 AG031862-13 and R01 AR078559 and additional funding from the CRUK Glasgow Centre (A25142) and Core Services at the Cancer Research UK Scotland Institute (A17196). R.A. was supported by the California Institute for Regenerative Medicine grant EDUC4-12813. L.M.M. was funded by core CRUK grants A15673 and A24452. Work in the lab of J.P.M. was supported by U24 CA220341, U24 CA194107, and U24 CA248457. A.T.W. was supported by NIH grants T15LM011271, F31CA257344, and T32CA067754. A.L. and work in the J.F.P. lab were supported by NIH grants R01AG068048, R01AG82708, UH3CA268103, and P01 AG062413 and The Glenn Foundation For Medical Research. M.L.H. and I.B. were supported by R01 AR078559. C.H.S. and K.Y.Y. were supported by U54 AG079758, R01 AG085498, and R01 CA287114. K.B. was CRUK Core funded (A29799). K.K. was funded by Blood Cancer UK (grant reference 23001), by an EHA Bilateral grant number ID BCG-202209-02649, and by the Mayo Clinic Robert and Arlene Kogod Center on Aging and the Mayo Clinic Department of Hematology. We thank members of the Biological Services Unit at CRUK Scotland Institute for help in animal maintenance, members of Histology services, especially Colin Nixon, for help in mouse tissue processing, and Tom Gilbey for help in cell sorting. We would like to thank the University of Pennsylvania High-throughput Biology Core and David C. Schultz for providing shRNA clones and preparations of lentivirus stocks for in vitro experiments. We thank all members of the Adams, Machesky, and Insall labs for critical discussions. Work in the lab of P.D.A. was supported by P01 AG031862‐13 and R01 AR078559 and additional funding from the CRUK Glasgow Centre (A25142) and Core Services at the Cancer Research UK Scotland Institute (A17196). R.A. was supported by the California Institute for Regenerative Medicine grant EDUC4‐12813. L.M.M. was funded by core CRUK grants A15673 and A24452. Work in the lab of J.P.M. was supported by U24 CA220341, U24 CA194107, and U24 CA248457. A.T.W. was supported by NIH grants T15LM011271, F31CA257344, and T32CA067754. A.L. and work in the J.F.P. lab were supported by NIH grants R01AG068048, R01AG82708, UH3CA268103, and P01 AG062413 and The Glenn Foundation For Medical Research. M.L.H. and I.B. were supported by R01 AR078559. C.H.S. and K.Y.Y. were supported by U54 AG079758, R01 AG085498, and R01 CA287114. K.B. was CRUK Core funded (A29799). K.K. was funded by Blood Cancer UK (grant reference 23001), by an EHA Bilateral grant number ID BCG‐202209‐02649, and by the Mayo Clinic Robert and Arlene Kogod Center on Aging and the Mayo Clinic Department of Hematology. We thank members of the Biological Services Unit at CRUK Scotland Institute for help in animal maintenance, members of Histology services, especially Colin Nixon, for help in mouse tissue processing, and Tom Gilbey for help in cell sorting. We would like to thank the University of Pennsylvania High‐throughput Biology Core and David C. Schultz for providing shRNA clones and preparations of lentivirus stocks for in vitro experiments. We thank all members of the Adams, Machesky, and Insall labs for critical discussions. Work in the lab of P.D.A. was supported by P01 AG031862‐13 and R01 AR078559 and additional funding from the Cancer Research UK Core Funding to the CRUK Glasgow Centre (A25142) and Cancer Research UK Core Funding to the CRUK Scotland Institute (A17196). R.A. was supported by the California Institute for Regenerative Medicine grant EDUC4‐12813. L.M.M. was funded by core CRUK grants A15673 and A24452. Work in the lab of J.P.M. was supported by U24 CA220341, U24 CA194107, and U24 CA248457. A.T.W. was supported by NIH grants T15LM011271, F31CA257344, and T32CA067754. A.L. and work in the J.F.P. lab were supported by NIH grants R01AG068048, R01AG82708, UH3CA268103, and P01 AG062413 and The Glenn Foundation For Medical Research. M.L.H. and I.B. were supported by R01 AR078559. C.H.S. and K.Y.Y. were supported by U54 AG079758, R01 AG085498, and R01 CA287114. K.B. was CRUK Core funded (A29799). K.K. was funded by Blood Cancer UK (grant reference 23001), by an EHA Bilateral grant number ID BCG‐202209‐02649, and by the Mayo Clinic Robert and Arlene Kogod Center on Aging and the Mayo Clinic Department of Hematology. Funding:
| Funders | Funder number |
|---|---|
| University of Pennsylvania | |
| 23001 | |
| A24452, A15673, U24 CA220341, U24 CA248457, EDUC4‐12813, U24 CA194107 | |
| Cancer Research UK | A17196, A25142 |
| BCG‐202209‐02649 | |
| National Institutes of Health | R01AG82708, R01AG068048, T15LM011271, UH3CA268103, P01 AG062413, T32CA067754, F31CA257344 |
| U54 AG079758, R01 CA287114, A29799, R01 AG085498 |
Keywords
- Animals
- Melanocytes/metabolism
- Histone Chaperones/metabolism
- Mice
- Cell Cycle Proteins/metabolism
- Mice, Knockout
- Embryonic Development/genetics
- Cell Differentiation
- Transcription Factors/metabolism
- Adult Stem Cells/metabolism
- Adult Stem Cells
- Histone Chaperones
- Melanocytes
- Embryonic Development
- Transcription Factors
- Cell Cycle Proteins
- Adult Stem Cells - metabolism - cytology
- Embryonic Development - genetics
- Transcription Factors - metabolism - genetics
- Cell Cycle Proteins - metabolism - genetics
- Histone Chaperones - metabolism - genetics
- Melanocytes - metabolism - cytology
Fingerprint
Dive into the research topics of 'Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver